To assess how payer costs for allogeneic BMT relate to patient characteristics and clinical complications, a retrospective cohort study of 402 persons undergoing allogeneic BMT between 1980 and 1987 at a university-based BMT center was designed to determine total inpatient payer costs, including hospital and physician costs, and number of days hospitalized during the first 180 days following BMT. The average total inpatient payer cost (in 1990 dollars) during the first 180 days following BMT ...Expand abstract
- Bone marrow transplantation
- Publication date:
- Source identifiers:
- Local pid:
- Copyright date:
Factors influencing third party payer costs for allogeneic BMT.
If you are the owner of this record, you can report an update to it here: Report update to this record